Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 15/20 | 1.00 |
| ▸ | HPGD | P15428 | 12/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 13/20 | 0.62 |
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | HTT | P42858 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 2/20 | 0.60 |
| ▸ | GAA | P10253 | 2/20 | 0.60 |
| ▸ | NPY1R | P25929 | 1/20 | 0.49 |
| ▸ | NPY2R | P49146 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Jatamansin SCHEMBL26671050 | 1.00 | KDM4E (1.00) | KDM4EHPGDCYP3A4HSD17B10ALDH1A1 | |
| Jatamansin SCHEMBL29385603 | 1.00 | KDM4E (1.00) | KDM4EHPGDCYP3A4HSD17B10ALDH1A1 | |
| Jatamansin SCHEMBL14523891 | 1.00 | KDM4E (1.00) | KDM4EHPGDCYP3A4HSD17B10ALDH1A1 | |
| Jatamansin SCHEMBL30634819 | 1.00 | KDM4E (1.00) | KDM4EHPGDCYP3A4HSD17B10ALDH1A1 | |
| SCHEMBL31349688 | 0.90 | KDM4E (0.81) | KDM4EHPGDCYP3A4HSD17B10ALDH1A1 | |
| SCHEMBL29707867 | 0.86 | KDM4E (0.76) | KDM4EHPGDCYP3A4HSD17B10ALDH1A1 | |
| Decursinol Angelate SCHEMBL14310264 | 0.79 | MAOA (0.76) | KDM4EHPGDCYP3A4HSD17B10ALDH1A1 | |
| Decursinol Angelate SCHEMBL3901157 | 0.79 | MAOA (0.76) | KDM4EHPGDCYP3A4HSD17B10ALDH1A1 | |
| Decursinol Angelate SCHEMBL4740622 | 0.79 | MAOA (0.76) | KDM4EHPGDCYP3A4HSD17B10ALDH1A1 | |
| Decursinol Angelate SCHEMBL3901154 | 0.79 | MAOA (0.76) | KDM4EHPGDCYP3A4HSD17B10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240165190-A1 | A HERBO-MINERAL METALLIC PHARMACEUTICAL KIT | SARDESHMUKH, Sadanand Prabhakar (IN) | 2024-05-23 | — | — | US | claimed |
| US-20230338329-A1 | CANNABINOID EMULSION COMPOSITION AND METHOD OF MANUFACTURING | GORE DOUGLAS (US) | 2023-10-26 | — | — | US | claimed |
| EP-4236690-A1 | ANTIVIRAL ESSENTIAL OIL COMPOSITIONS | Erdogmus, Hüseyin (TR) | 2023-09-06 | — | — | EP | claimed |
| WO-2022269576-A1 | A NEW DRUG DELIVERY SYSTEM OF EFFERVESCENT PRODUCTS | SCITECH SPECIALITIES PRIVATE LIMITED (IN) | 2022-12-29 | — | — | WO | claimed |
| US-20220370535-A1 | ANTIVIRAL ESSENTIAL OIL COMPOSITIONS | ERDOGMUS, HÜSEYIN (TR) | 2022-11-24 | — | — | US | claimed |
| WO-2022195415-A1 | A HERBO-MINERAL METALLIC PHARMACEUTICAL KIT | SARDESHMUKH SADANAND PRABHAKAR (IN) | 2022-09-22 | — | — | WO | claimed |
| WO-2022093141-A1 | ANTIVIRAL ESSENTIAL OIL COMPOSITIONS | ERDOGMUS HUESEYIN (TR) | 2022-05-05 | — | — | WO | claimed |
| US-20260117458-A1 | METHODS AND SYSTEMS FOR PLASMA COLOURATION AND PIGMENT FIXATION | XEFCO PTY LTD (AU) | 2026-04-30 | — | — | US | disclosed |
| EP-4136067-B1 | ODORANTS AND COMPOSITIONS COMPRISING ODORANTS | S H KELKAR AND COMPANY LTD (IN) | 2026-04-15 | — | — | EP | disclosed |
| WO-2026039879-A1 | METHOD AND DEVICE FOR COLOURATION OF SUBSTRATES | XEFCO PTY LTD (AU) | 2026-02-26 | — | — | WO | disclosed |
| US-12545852-B2 | Odorants and compositions comprising odorants | S H KELKAR AND COMPANY LIMITED (IN) | 2026-02-10 | — | — | US | disclosed |
| EP-3697878-B1 | USE OF ODORANTS AND COMPOSITIONS COMPRISING ODORANTS | S H KELKAR AND COMPANY LTD (IN) | 2026-01-28 | — | — | EP | disclosed |
| US-12522780-B2 | Odorants and compositions comprising odorants | S H KELKAR AND COMPANY LIMITED (IN) | 2026-01-13 | — | — | US | disclosed |
| US-8772252-B2 | Coumarin compounds as melanogenesis modifiers and uses thereof | NEW YORK UNIVERSITY (US) | 2014-07-08 | — | — | US | disclosed |
| US-8563754-B2 | Compounds, compositions and methods for preventing skin darkening | NEW YORK UNIVERSITY (US) | 2013-10-22 | — | — | US | disclosed |
| US-8563754-B2 | Compounds, compositions and methods for preventing skin darkening | NEW YORK UNIVERSITY (US) | 2013-10-22 | — | — | US | disclosed |
| US-20120220545-A1 | COUMARIN COMPOUNDS AS MELANOGENESIS MODIFIERS AND USES THEREOF | NEW YORK UNIVERSITY | 2012-08-30 | — | — | US | disclosed |
| US-20120220545-A1 | COUMARIN COMPOUNDS AS MELANOGENESIS MODIFIERS AND USES THEREOF | NEW YORK UNIVERSITY | 2012-08-30 | — | — | US | disclosed |
| US-20110190229-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR PREVENTING SKIN DARKENING | NEW YORK UNIVERSITY | 2011-08-04 | — | — | US | disclosed |
| US-20110190229-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR PREVENTING SKIN DARKENING | NEW YORK UNIVERSITY | 2011-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545852-B2 | Odorants and compositions comprising odorants | ENY2, CDY1; CDY1B, CHRM5 | KDM4E 1249/4885HPGD 2292/4885CYP3A4 1747/4885 |
| US-20260117458-A1 | METHODS AND SYSTEMS FOR PLASMA COLOURATION AND PIGMENT FIXATION | FUCA2, TYR, PRPF8 | KDM4E 2494/4885HPGD 3435/4885CYP3A4 225/4885 |
| US-20120220545-A1 | COUMARIN COMPOUNDS AS MELANOGENESIS MODIFIERS AND USES THEREOF | TYR, MC1R, MITF | KDM4E 79/4885HPGD 2055/4885CYP3A4 573/4885 |
| US-20220370535-A1 | ANTIVIRAL ESSENTIAL OIL COMPOSITIONS | CYP51A1, NR1H2, CYP2R1 | KDM4E 601/4885HPGD 1388/4885CYP3A4 90/4885 |
| US-20110190229-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR PREVENTING SKIN DARKENING | TYR, MC1R, MITF | KDM4E 274/4885HPGD 574/4885CYP3A4 809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.